Manufacturers will be obliged to make to the instructions to drugs trials data

The Ministry of health of the Russian Federation is preparing a bill that would force pharmaceutical manufacturers to make the instruction on the drug administration data post-marketing studies, writes “the parliamentary newspaper”.

The relevant amendments, the Ministry plans to amend the law “On circulation of medicines”. To make changes to the manual must be the holder or the owner of the registration certificate of medicines.

The Ministry believed that the new requirements will establish the procedure for granting and accounting of the results of application of drugs in medical organizations, which will increase the effectiveness of the control and safety of the products being in civil circulation.

It is expected that the new rules will take effect in January 2021.

Leave a Reply

Your email address will not be published. Required fields are marked *


For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]